tolvaptan has been researched along with Coronary Artery Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, CY; Fang, HY; Lee, WC | 1 |
| Amano, A; Kato, TS; Kuroda, K; Matsushita, S; Murata, M; Nakamura, H; Shimada, A; Suzuki, H; Yamamoto, T; Yokoyama, Y | 1 |
1 trial(s) available for tolvaptan and Coronary Artery Disease
| Article | Year |
|---|---|
The effect of tolvaptan on renal excretion of electrolytes and urea nitrogen in patients undergoing coronary artery bypass surgery.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Urea Nitrogen; Coronary Artery Bypass; Coronary Artery Disease; Diuresis; Dose-Response Relationship, Drug; Electrolytes; Female; Follow-Up Studies; Humans; Male; Prognosis; Prospective Studies; Renal Elimination; Tolvaptan | 2016 |
1 other study(ies) available for tolvaptan and Coronary Artery Disease
| Article | Year |
|---|---|
Tolvaptan rescue contrast-induced acute kidney injury: A case report.
Topics: Acute Kidney Injury; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Contrast Media; Coronary Artery Disease; Female; Humans; Hyponatremia; Middle Aged; Oliguria; Percutaneous Coronary Intervention; Tolvaptan | 2018 |